Holding(s) in Company
20 Novembre 2008 - 5:04PM
UK Regulatory
RNS Number : 6146I
Protherics PLC
20 November 2008
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 20 November 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that, on 19 November 2008, the following notification of interest in the ordinary
share capital of the Company was received from Aviva plc.
1. Reason for the notification (please tick the
appropriate box or boxes)
A disposal voting rights X
An acquisition or disposal of financial instruments
which may result in the acquisition of shares
already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) Aviva plc & its subsidiaries
subject to the notification
obligation:
3. Full name of shareholder(s) Registered Holder:
(if different from 2.):
BNY Norwich Union Nominees Limited
5,959,368*
Chase GA Group Nominees Limited
19,321,240*
Chase Nominees Limited
879,543*
CUIM Nominee Limited
4,366,418*
Vidacos Nominees Limited
65,125*
*denotes direct interest
BNP Paribas - London
636,429
Chase Nominees Limited
3,065,451
State Street Nominees Limited
9,428,137
Vidacos Nominees Limited
1,603,080
4. Date of the transaction 18 November 2008
(and date on which the
threshold is crossed or
reached if different):
5. Date on which issuer 19 November 2008
notified:
6. Threshold(s) that is/are 13% to 12% Change at Combined Interest
crossed or reached: level
7. Notified details:
A: Voting rights attached to shares
Class/type of shares Situation previous to the Triggering Resulting situation after the triggering transaction
if possible using the ISIN transaction
CODE
Number of Shares Number of Voting Number of shares Number of voting rights % of voting
Rights rights
Direct Direct Indirect Direct Indirect
Ordinary Shares 45,971,166
GB0007029209 45,971,166 30,591,694 8.73% 4.20%
30,591,694 14,733,097
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ Conversion Number of voting % of voting rights
Period/ Date rights that may be
acquired if the
instrument is
exercised/
converted.
N/A
Total (A+B)
Number of voting rights % of voting rights
45,324,791 12.93%
8. Chain of controlled undertakings through which the voting rights and/or
the financial instruments are effectively held, if applicable :
The voting rights are managed and controlled by Aviva Investors Global
Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group
Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva
Investors Holdings Limited)
Proxy Voting:
9. Name of the proxy holder: See Section 3
10. Number of voting rights proxy holder will cease to
hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information: Figures are based on a revised total number of
voting rights of 350,427,481
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLQBLFLVFBBFBX
Grafico Azioni Protherics (LSE:PTI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Protherics (LSE:PTI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Protherics (Borsa di Londra): 0 articoli recenti
Più Protherics Plc Articoli Notizie